January 2012

Healthcare Decisions in the Age of Social Networks: The Facts About Influencers, Trust and Privacy

December 22, 2011

Clearly, social networks are an integral part of our lives today. But how much do they impact healthcare decisions? Do people trust — and act on — what they read online? To find out, SSI conducted a study with more than 1,450 U.S. consumers 13 and older. About half of our respondents are from our […]

Search and Social Media for the Pharmaceutical Industry

December 22, 2011

Much has been said about the role of social media as a marketing vehicle. It offers customers and audiences a way to interact with brands like never before. The paradigm of audience has shifted as our “push” messaging has evolved to a conversation. In the pharmaceutical industry, we are looking to participate in this conversation […]

Nearly All U.S. Doctors are Now on Social Media; Shouldn’t You be Too?

December 22, 2011

Pharma may be a late adopter of social media, but doctors are all in. According to a recent American Medical News article, Frost & Sullivan found that 84% of doctors use social media for personal purposes. This was confirmed by a QuantiaMD study in which nearly 90% of physicians reported they used at least one […]

Healthcare And Social Media: A Winning Formula

December 22, 2011

Healthcare and Social Media: A Winning Formula Do you know what physicians are saying to each other about your company and its products? Could you identify the top three fears of patients suffering from a chronic condition treated by your market leading therapy? Social media sites can get pharmacos closer to answering each of these […]

Six Social Shifts: Trends Affecting Pharma Now

December 22, 2011

Like all things digital, the social media environment is moving so fast that even news from just three months ago seems old. The regulatory environment of pharma exacerbates the challenge to stay ahead of this social world. The pharma industry was anything but an early adopter in the social space. The waiting game was two-fold, […]

Engaging Healthcare Professionals with Social Media

December 22, 2011

Social media and technology have turned healthcare consumers into e-patients. The “e” is no longer for electronic, but rather for evolved, empowered, and engaged. E-patients are evolved to the point of being screen agnostic when it comes to digital media consumption. They are empowered to make choices about how they interact online, and what they […]

Hitting the Social Comfort Zone

December 22, 2011

Social Media Carolyn Gretton Pharmaceutical and biotechnology companies are shaking off their hesitance to employ social media tactics by forgoing potential marketing applications in favor of connecting with patients and providers in conversations that engage and inform. Most experts would likely agree that until recently, pharma and biotech companies have taken a toe-dip approach to […]

Insights from the C-Suite: Specialty Pharma

December 22, 2011

The growing U.S. specialty pharmaceutical market comprises more than 90 companies marketing more than 550 prescription pharmaceutical products and is valued at about $21 billion, according to MCD Group. According to MCD Group, specialty pharmaceuticals are mainly prescribed by clinical specialists and aimed at well-defined patient groups. In many cases, specialty products address large unmet […]

Making a Difference

December 22, 2011

Taren Grom Dr. Brad Thompson, Executive Chairman, CEO, and President of Oncolytics Biotech Inc., is excited about the opportunities that his company and the biotech field in ­general can have to make transformative changes in the standard of care for patients. Dr. Brad Thompson has a personal connection to the biotechnology field, particularly in the […]

Global: R&D Outsourcing

December 22, 2011

Robin Robinson Outsourcing has always been about cutting costs and creating efficiencies, and today’s pressures have made the R&D process more global than ever. Myriad pressures have the industry looking toward global R&D outsourcing as a life raft in a sea of change. A U.K. report by Deloitte and Thomson Reuters surveyed a dozen pharmaceutical […]

Forecasting Pharma’s Future

December 22, 2011

Forecasting Pharma’s Future Denise Myshko Given the volatility of today’s financial landscape, ­companies, more than ever, need a robust forecasting strategy that is clear, effective, and accurate. As companies seek to negotiate the volatility of emerging markets, the uncertainties of healthcare reforms, and changing customer demands, accurate forecasting will need to come to the fore […]

The Littlest Patients

December 22, 2011

Denise Myshko Incentives and mandates have spurred drugmakers to test many products in ­ children and to enhance the pediatric information provided on drug ­labels. But experts say there is still a long way to go to address this ­specialty ­population. Over the past 15 years, biopharmaceutical companies have made great strides in studying how […]

Multichannel Measurement: It’s Not All About ROI

December 22, 2011

Robin Robinson Measuring the effectiveness of every channel now available — from traditional to nontraditional, online and off — is at best difficult, especially as advances in technology and social media networks continually create new ways to reach the consumer, and, at worst, impossible when it comes to detangling the interwoven web of channels, some […]

Pharma 3.0 Next Steps

December 22, 2011

Robin Robinson Pharma Expands Disease ­Categories of 3.0 Efforts Between 2006 and 2009, 24% of Pharma 3.0 initiatives focused first on ­diabetes and metabolics. In 2010, oncology moved to the top with 15% of the year’s ­initiatives, and diabetes and metabolics tied for second with ­immunoscience/inflammatory diseases, at 12% each. Source: EY The industry ushers […]

Talent Pool

December 22, 2011

executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Alex AZAR Maria CROWE Dave RICKS Lilly Makes Management Changes Lilly has announced a number of key management appointments. Alex Azar has been promoted to president of Lilly USA, the company’s largest affiliate. Mr. Azar has been VP of U.S. managed healthcare […]

Tools of the Trade

December 22, 2011

New electronic and web-based applications, sites, and technologies By Carolyn Gretton ImpactRx Adds Tablet Detailing to Analytics Offerings Trend: Growing physician adoption of tablet computers is prompting pharma brand teams to design and execute messaging strategies that more effectively employ tablet technology. TabletImpact, an offering from ImpactRx’s consulting analytics practice, provides insight into the execution […]

What’s New

December 22, 2011

New healthcare-related products, services, and companies By Carolyn Gretton Parexel Adds Commercialization to Repertoire Trend: A growing number of clinical development service providers are using their rich store of data and experience gleaned from clinical trial management to expand into commercialization. Parexel International has expanded and fully integrated its commercialization services to help biopharmaceutical clients […]

PharmaTrax

December 22, 2011

Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Pharma Turning to Health Outcomes Liaison Teams Trend: Trailblazing pharma companies are assembling elite health outcomes liaison (HOL) teams ­focused on market access priorities and supporting these groups with extensive resources and quality ongoing training. Health outcomes liaisons (HOLs) forge connections with key target […]

Social Media

December 22, 2011

Social Media trends, regs, and apps By Robin Robinson Google+ Or Minus For Pharma? Trend Watch: Will The Industry Use Google+ Business Pages? No Need to Rush, Experts Say In June 2011, Google launched Google+ for personal use, and many in the social media industry debated whether a G+ for business would be forthcoming. Not […]

UpFront

December 22, 2011

In Memoriam… Robert L. (Bob) Gerbig, co-founder and former CEO of Gerbig, Snell/Weisheimer & Associates (GSW, now part of inVentiv), has died at 66. Mr. Gerbig began his career in pharmaceuticals in 1969 with Marion Merrell-Dow, where he held various positions in sales, marketing, and merchandising. In 1977, he left Abbott and teamed with Rick […]

Letter from the Editor

December 22, 2011

The way forward…

FEEDBACK